21 reports

Transplant type segment of HSCT market was divided into autologous transplant and allogeneic transplant.

  • Stem Cell Transplant
  • APAC
  • World
  • Forecast
  • Market Size

Hematopoietic Stem Cell Transplantation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ##.

  • Stem Cell Transplant
  • United States
  • World
  • Demand
  • Product Initiative

Some of the prominent trends that the market is witnessing include technological advancements in regenerative stromal cell therapy, development of transplantation activity across the globe, recent technological developments of Hematopoietic Stem Cell Transplantation and growth oppo

  • Stem Cell Transplant
  • APAC
  • World
  • Forecast
  • Market Size

Hematopoietic Stem Cell Transplantation - Epidemiology Forecast to 2027 ##.

  • Stem Cell Transplant
  • France
  • Germany
  • Italy
  • Spain

Drug A: Company ## ##. ##. ##.

  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation
  • United States
  • Market Shares

ReNeuron Group Plc (UK) ##.

  • Stem Cell Transplant
  • Europe
  • United States
  • World
  • Market Shares

(USA) ##.

  • Stem Cell Transplant
  • Europe
  • United States
  • World
  • Market Shares

(USA) ##.

  • Stem Cell Transplant
  • Europe
  • United States
  • World
  • Market Shares

(USA) ##.

  • Stem Cell Transplant
  • Europe
  • United States
  • World
  • Market Shares

COMPANY SNIPPETS.............. ## ##.

  • Blood Supply
  • Stem Cell Transplant
  • China
  • United States
  • Market Shares

(USA) ##.

  • Cancer
  • Stem Cell Transplant
  • United States
  • World
  • Market Shares
  • Clinical Trials by G7 Countries: Proportion of Stem Cell Transplantation to Immunology Clinical Trials
  • Stem Cell Transplantation Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Stem Cell Transplantation Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Stem Cell Transplantation Global Clinical Trials Review, H2, 2016" provides an overview of Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical...

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • World
  • Product Initiative

GVHD is a disease caused when cells from a donated stem cell graft attack the normal tissues of the transplant patient.

  • Stem Cell Transplant
  • France
  • Germany
  • Japan
  • United States

GVHD is one of the severe complications associated with Hematopoietic stem cell transplantations (HSCTs).

  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation
  • United States
  • Market Size
  • Mar 30, 2016: FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
  • Aug 02, 2016: CMS Grants New Technology Add-On Payment to Defitelio for the Treatment of Hepatic Veno- Occlusive Disease with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) – Pipeline Review, H1 2018 Summary Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) pipeline Target constitutes close to 9 molecules. Out of which...

  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Therapy
  • United States
  • Product Initiative
  • Mar 30, 2016: FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
  • Aug 02, 2016: CMS Grants New Technology Add-On Payment to Defitelio for the Treatment of Hepatic Veno- Occlusive Disease with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2017 Summary Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) pipeline Target constitutes close to 10 molecules. Out of which approximately 3 molecules...

  • Hospital
  • Stem Cell Transplant
  • Therapy
  • United States
  • Product Initiative
  • Clinical Trial profile. 81 Trial Title
  • Clinical Trial profile. 99 Trial Title

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017" provides an overview of Hematopoietic Stem Cell Transplantation clinical trials scenario. This report provides...

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • World
  • Product Initiative
  • HSC-835 - DRUG PROFILE

GVHD is a serious, life-threating complication of stem cell transplantation, affecting over ##% of all patients undergoing allogeneic stem cell transplantation.

  • Blood Disease
  • Cell Therapy
  • Stem Cell Transplant
  • Transplantation
  • Athersys, Inc.
  • ACTIMAB-B - DRUG PROFILE

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016’, provides an overview of the Hematopoietic Stem Cell Transplantation pipeline landscape. The report provides comprehensive information on the therapeutics...

  • Cell Therapy
  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation
  • Athersys, Inc.

Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2018 ##.

  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation
  • Untitled
  • title

Juvenile Myelomonocytic Leukemia (JMML) clinical trials report from VPA Research provides comprehensive analysis and trends in global Juvenile Myelomonocytic Leukemia (JMML) disease clinical trials. The research work analyzes the evolution of Juvenile Myelomonocytic Leukemia (JMML) clinical trial trends across countries and regions. The...

  • Cancer
  • Leukemia
  • Stem Cell Transplant
  • United States
  • Product Initiative